1-Benzyl-4-ethylpiperazine

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 1-Benzyl-4-ethylpiperazine
• 化学式: C₁₃H₂₀N₂
• mdl: MFCD01452087
• 分子量: 204.31
• InChiKey: MGBUFZZSXMCADL-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.1
• 重原子数：
  15
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.538
• 拓扑面积：
  6.5
• 氢给体数：
  0
• 氢受体数：
  2

文献信息

• Novel Anthra [1, 2-d]imidazole-6,11-dione Derivatives, Preparation Method and application thereof
  申请人：HUANG Hsu-Shan

  公开号：US20110207719A1

  公开（公告）日：2011-08-25

  A series of novel anthra[1,2-d]imidazole-6,11-dione derivatives, and the preparation method and application of said derivatives, wherein said application includes a pharmaceutical composition containing said derivatives for treating cancer, and said application involves effects of said derivatives for inhibiting telomerase activity, inhibiting the growth of cancer cell, treating cancer and the like.

  一系列新型蒽[1,2-d]咪唑-6,11-二酮衍生物，以及所述衍生物的制备方法和应用，其中所述应用包括含有所述衍生物的用于治疗癌症的药物组合物，所述应用涉及所述衍生物抑制端粒酶活性、抑制癌细胞生长、治疗癌症等效果。
• METHOD FOR PRODUCING N-SUBSTITUTED AMINE COMPOUNDS THROUGH CATALYZED ALKYLATION
  申请人：Chinese Academy of Sciences Lanzhou Institute of Chemical Physics,

  公开号：US20140039181A1

  公开（公告）日：2014-02-06

  The invention relates to a method for producing a N-substituted amine compound by catalyzed alkylation. The method uses amine and alcohol or two kinds of amines as the reaction materials, employs composite metal oxides catalyst at a reaction temperature of 80-180° C. to catalyze the reaction for 6-36 hours, so as to produce the N-substituted amine compound. The reaction condition of the method of the invention is relatively moderate, using a catalyst made of cheap non-noble metals, which is non-caustic and easy to be separated and reused. The reaction does not need any medium and has relatively high conversion rate and selectivity.

  该发明涉及一种通过催化烷基化制备N-取代胺化合物的方法。该方法使用胺和醇或两种胺作为反应物质，在80-180°C的反应温度下，采用复合金属氧化物催化剂催化反应6-36小时，从而产生N-取代胺化合物。该发明方法的反应条件相对温和，使用由廉价非贵金属制成的催化剂，不具腐蚀性，易于分离和再利用。该反应不需要任何介质，具有相对较高的转化率和选择性。
• 5-CHLORO-2-DIFLUOROMETHOXYPHENYL PYRAZOLOPYRIMIDINE COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF
  申请人：Genentech, Inc.

  公开号：US20150336962A1

  公开（公告）日：2015-11-26

  Compounds of Formula (00A) and methods of use as Janus kinase inhibitors are described herein.

  这里描述了化合物的公式（00A）及其作为Janus激酶抑制剂的使用方法。
• TETRAHYDROISOQUINOLINE SULFONAMIDE DERIVATIVES, THE PREPARATION THEREOF, AND THE USE OF THE SAME IN THERAPEUTICS
  申请人：Diaz Martin Antonio Juan

  公开号：US20070105834A1

  公开（公告）日：2007-05-10

  The invention relates to tetrahydroisoquinoline sulfonamide compounds (of formula (1) as defined in the specification), their preparation and their use in therapies for the treatment of central nervous system diseases such as vigilance and sleep disorders, narcolepsy, Alzheimer's disease and other dementias, Parkinson's disease, attention disorders in hyperkinetic children, memory and learning disorders, epilepsy, schizophrenia, moderate cognitive disorders, depression, anxiety, sexual dysfunction, dizziness and travel sickness.

  该发明涉及四氢异喹啉磺胺类化合物（如规范中定义的式（1）），其制备以及在治疗中枢神经系统疾病方面的应用，如警觉和睡眠障碍、嗜睡症、阿尔茨海默病和其他痴呆症、帕金森病、多动症儿童的注意力障碍、记忆和学习障碍、癫痫、精神分裂症、中度认知障碍、抑郁症、焦虑症、性功能障碍、头晕和晕车症。
• Indenoisoquinolinone analogs and methods of use thereof
  申请人：Jagtap Prakash

  公开号：US20070049555A1

  公开（公告）日：2007-03-01

  The present invention relates to Indenoisoquinolinone Analogs, compositions comprising an effective amount of an Indenoisoquinolinone Analog and methods for treating or preventing an inflammatory disease, a reperfusion injury, diabetes mellitus, a diabetic complication, reoxygenation injury resulting from organ transplantation, an ischemic condition, a neurodegenerative disease, renal failure, a vascular disease, a cardiovascular disease, cancer, a complication of prematurity, cardiomyopathy, retinopathy, nephropathy, neuropathy, erectile dysfunction or urinary incontinence, comprising administering to a subject in need thereof an effective amount of an Indenoisoquinolinone Analog.

  本发明涉及Indenoisoquinolinone类似物，包括有效量的Indenoisoquinolinone类似物的组合物，以及用于治疗或预防炎症性疾病、再灌注损伤、糖尿病、糖尿病并发症、器官移植引起的再氧化损伤、缺血状况、神经退行性疾病、肾功能衰竭、血管疾病、心血管疾病、癌症、早产并发症、心肌病、视网膜病、肾病、神经病、勃起功能障碍或尿失禁的方法，包括向需要治疗的受体内给予有效量的Indenoisoquinolinone类似物。